Insider Selling: Plexus Corp. (NASDAQ:PLXS) Insider Sells 1,200 Shares of Stock

Plexus Corp. (NASDAQ:PLXS) insider Frank Zycinski sold 1,200 shares of Plexus stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $140.84, for a total value of $169,008.00. Following the transaction, the insider now owns 723 shares of the company’s stock, valued at $101,827.32. The trade was a 62.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Plexus Price Performance

PLXS traded down $1.46 during trading on Wednesday, hitting $139.37. The company’s stock had a trading volume of 172,655 shares, compared to its average volume of 181,123. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $3.77 billion, a price-to-earnings ratio of 32.34 and a beta of 0.89. The business’s fifty day simple moving average is $157.54 and its 200 day simple moving average is $144.24. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $172.89.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, equities research analysts forecast that Plexus Corp. will post 5.94 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. KeyCorp started coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Stifel Nicolaus assumed coverage on shares of Plexus in a research note on Tuesday, February 4th. They set a “hold” rating and a $152.00 price objective on the stock. Benchmark reiterated a “buy” rating and issued a $165.00 target price on shares of Plexus in a research note on Wednesday, January 22nd. Needham & Company LLC raised their price target on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a report on Monday, November 18th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $163.00.

Hedge Funds Weigh In On Plexus

A number of hedge funds have recently modified their holdings of the business. Pacer Advisors Inc. purchased a new position in Plexus in the fourth quarter valued at $107,489,000. GSA Capital Partners LLP acquired a new stake in shares of Plexus in the 3rd quarter valued at $899,000. Victory Capital Management Inc. lifted its position in shares of Plexus by 3.9% during the 3rd quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company’s stock worth $27,367,000 after purchasing an additional 7,483 shares during the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI increased its holdings in Plexus by 62.6% in the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 13,346 shares of the technology company’s stock valued at $1,825,000 after buying an additional 5,138 shares during the last quarter. Finally, Stifel Financial Corp acquired a new stake in Plexus in the third quarter valued at $332,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.